SCHEMBL1993409

SCHEMBL1993409

Cc1ccc2nc(N3CCN(C)CC3)nc(CC(N)=O)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 8/20 0.50
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ATM Q13315 2/20 0.47
HTR3A P46098 5/20 0.47
KDM4E B2RXH2 4/20 0.46
CASP1 P29466 2/20 0.46
CASP7 P55210 2/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALDH1A1 P00352 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
ADRB2 P07550 1/20 0.45
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCE Q02156 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990158 0.87 HRH4 (0.49) HRH4HTR3AKDM4EHSD17B10MAPT
SCHEMBL1991112 0.87 HRH4 (0.65) HRH4HTR3AKDM4ECASP1CASP7
SCHEMBL1998966 0.85 EHMT1 (0.51) HRH4MEN1KMT2AHTR3AKDM4E
SCHEMBL1993141 0.85 HRH4 (0.56) HRH4MEN1KMT2AATMKDM4E
SCHEMBL1993681 0.84 HRH4 (0.61) HRH4HTR3AKDM4EALDH1A1GLA
SCHEMBL1993947 0.81 PRKCB (0.45) HRH4HTR3AKDM4EALDH1A1L3MBTL1
SCHEMBL1995226 0.79 LATS1 (0.45) HRH4HTR3AKDM4EALDH1A1GLA
SCHEMBL1991360 0.78 HRH4 (0.51) HRH4HTR3AKDM4ECASP1CASP7
SCHEMBL1995864 0.77 PIK3R1 (0.43) HRH4HTR3AKDM4ETSHRHSD17B10
SCHEMBL1994137 0.77 HRH4 (0.50) HRH4HTR3AKDM4EALDH1A1PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO HRH4 249/4885MEN1 427/4885KMT2A 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.